3
QUIZ PAGE MAY 2013 A Case of Postpartum Acute Kidney Injury CLINICAL PRESENTATION A 30-year-old Asian woman presented with oligu- ria, edema, and breathlessness for the previous 10 days and was found to have severe acute kidney injury. She was gravida 2, para 2 and had under- gone lower segment caesarean section at term 1 month earlier. Her pregnancy was uncomplicated: she had normal kidney function and no pre- eclampsia. Her previous pregnancy also was un- eventful and delivered by lower segment caesar- ean section by choice. On evaluation, blood pressure was high at 150/90 mm Hg and urinalysis showed proteinuria and hematuria. She had no evidence of hypertensive retinopathy. Blood work showed a creatinine level of 13.2 mg/dL (corresponding to an estimated glomerular filtration rate of 3 mL/min/ 1.73 m 2 using the 4-variable Modification of Diet in Renal Disease [MDRD] Study equation), a hemo- globin level of 6.4 g/dL, and a platelet count of 2,700,000/L. Peripheral smear showed normo- cytic normochromic anemia with occasional sphero- cytes, teardrop cells, target cells, acanthocytes, and no evidence of significant red blood cell fragmenta- tion. Liver function and coagulation profile results were normal, and lactate dehydrogenase level was mildly elevated at 730 U/L (reference range, 240- 480 U/L). Results of C3, antinuclear antibody, proteinase 3 and myeloperoxidase antinuclear cyto- plasmic antibody, and antiphospholipid antibody screens were negative. A kidney ultrasound showed normal-sized kidneys with increased echogenicity in the renal cortex. She was oligoanuric, and hemo- dialysis treatment was initiated. A kidney biopsy was performed (Figs 1-3). What does the biopsy show? What diseases cause these pathologic findings? How should this patient be treated? Figure 1. Moderate degree of multilayering of the intima of small arteries with reactive endothelium. Red blood cells are present between the hyperplastic intimal layers (trichrome stain). Figure 2. Preglomerular arterioles show hyperplasia of the intima with swollen endothelium. The glomerulus shows congestion of the cap- illaries without inflammation (Jones silver methenamine stain). Figure 3. The glomerulus shows focal wrinkling of the capillary basement membranes with occasional double contours (Jones silver methenamine stain). QUIZ PAGE Am J Kidney Dis. 2013;61(5):xxv-xxvii xxv

Quiz Page MAY 2013

Embed Size (px)

Citation preview

Page 1: Quiz Page MAY 2013

QUIZ PAGEMAY 2013

A Case of Postpartum Acute Kidney Injury

arteries with reactive endothelium. Red blood cells are presentbetween the hyperplastic intimal layers (trichrome stain).

illaries without inflammation (Jones silver methenamine stain).

QU

I

CLINICAL PRESENTATIONA 30-year-old Asian woman presented with oligu-ria, edema, and breathlessness for the previous 10days and was found to have severe acute kidneyinjury. She was gravida 2, para 2 and had under-gone lower segment caesarean section at term 1month earlier. Her pregnancy was uncomplicated:she had normal kidney function and no pre-eclampsia. Her previous pregnancy also was un-eventful and delivered by lower segment caesar-ean section by choice. On evaluation, blood pressurewas high at 150/90 mm Hg and urinalysis showedproteinuria and hematuria. She had no evidenceof hypertensive retinopathy. Blood work showeda creatinine level of 13.2 mg/dL (corresponding toan estimated glomerular filtration rate of 3 mL/min/1.73 m2 using the 4-variable Modification of Dietin Renal Disease [MDRD] Study equation), a hemo-globin level of 6.4 g/dL, and a platelet count of2,700,000/�L. Peripheral smear showed normo-cytic normochromic anemia with occasional sphero-cytes, teardrop cells, target cells, acanthocytes, andno evidence of significant red blood cell fragmenta-tion. Liver function and coagulation profile resultswere normal, and lactate dehydrogenase level wasmildly elevated at 730 U/L (reference range, 240-480 U/L). Results of C3, antinuclear antibody,proteinase 3 and myeloperoxidase antinuclear cyto-plasmic antibody, and antiphospholipid antibodyscreens were negative.Akidney ultrasound showednormal-sized kidneys with increased echogenicityin the renal cortex. She was oligoanuric, and hemo-dialysis treatment was initiated. A kidney biopsywas performed (Figs 1-3).

� What does the biopsy show?

� What diseases cause thesepathologic findings?

� How should this patient be treated?

bs

Am J Kidney Dis. 2013;61(5):xxv-xxvii

Figure 1. Moderate degree of multilayering of the intima of small

Figure 2. Preglomerular arterioles show hyperplasia of the intima withswollen endothelium. The glomerulus shows congestion of the cap-

Figure 3. The glomerulus shows focal wrinkling of the capillary

asement membranes with occasional double contours (Jonesilver methenamine stain).

ZPA

GExxv

Page 2: Quiz Page MAY 2013

QU

IZPA

GE

QUIZ PAGEMAY 2013

ANSWERS

D

D

DISCUSSION

f What does the biopsyshow?

Figure 1 shows a moderate degreeof multilayering of the intima ofsmall arteries with reactive endothe-lium. Red blood cells are presentbetween the hyperplastic intimallayers. Figure 2 shows preglomeru-lar arterioles with hyperplasia ofthe intima with swollen endothe-lium. The glomerulus shows con-gestion of the capillaries withoutinflammation. Figure 3 shows aglomerulus with focal wrinkling ofthe capillary basement membranesand occasional double contours.

Thrombotic microangiopathy(TMA) is the pathologic lesioncharacterized by occluded mi-crovessels due to swollen endothe-lial cells and subendothelial aggre-gation of platelets, proteins, anddebris. All diseases associated withTMA are characterized by kidneybiopsy findings of endothelial in-jury and thrombus formation.1 Thepathologic findings primarily in-volve glomeruli and vessels, can bedivided into acute and chronic le-sions, and do not distinguish be-tween the multiple disease entitiesassociated with TMA.

f What diseases causethese pathologicfindings?

The way TMA disorders are clas-sified has fluctuated over time,and even now the term TMA isinappropriately treated as if it weresynonymous with thromboticthrombocytopenic purpura-hemo-

lytic uremic syndrome (TTP-

(q

xxvi

Table 1. Features and Treatments of Various Causes of TMA

Causes ofTMA Features Treatment

� HUS Cause of childhood HUS in 90% ofcases; caused by verocytotoxin-producing Escherichia coli

Treatment is supportive, butplasma exchange may be usedin patients with significantneurologic symptoms;eculizumab may be helpful

� HUSa Cause of childhood HUS in 10% ofcases; disease of alternatecomplement pathway, may befamilial

Plasma exchange is the first-linetherapy; eculizumab may behelpful

TTP Severe deficiency of ADAMTS13(genetic or acquired) commonly isobserved, no other obvious causehas been found

Plasma exchange is the treatmentof choice; in resistant cases,glucocorticoids, rituximab, orcyclosporine may be helpful

Pregnancy orpostpartumHUS

Risk of recurrence with subsequentpregnancies; can be difficult todifferentiate clinically andhistologically from HELLPsyndrome; progression past 3 dpostpartum can help differentiatefrom HELLP syndrome

Treatment is the same as adultTTP-HUS; during pregnancy, ifdistinction from HELLPsyndrome is difficult, delivery isindicated

Drugsb Quinine is the most common causeand the only drug with documenteddrug-dependent antibodies; oftenpresents with slowly progressivekidney failure, new/acceleratedhypertension, and bland urinarysediment

Often reversible withdiscontinuation of the offendingdrug; plasma exchangeineffective; may respond torituximab

Disseminatedmalignancy

Normal or slightly reduced ADAMTS13levels; high LDH; often occurs withmucin-producing adenocarcinoma

Plasma exchange ineffective

Transplant-associatedTMA

Schistocytes �4% of RBCs; de novoprolonged or progressivethrombocytopenia; high serum LDHand low haptoglobin

No role for plasma exchange; mayrespond to rituximab

APS Kidney involvement in 25% of primaryAPS patients; clinical spectrumvaries from mild proteinuria to acute/subacute kidney failure and oftenmarked hypertension

May respond to eitherplasmapheresis orcorticosteroids andmaintenance anticoagulation

Sclerodermakidney

Abrupt onset of severe hypertension;bland urine sediment withprogressive kidney failure

ACE inhibitors are the drugs ofchoice; may progress to ESRDin 20%-50% despite treatment

Note: Apart from the causes listed here, TMA also can be caused by malignant nephroscle-rosis, radiation nephritis, and human immunodeficiency virus infection.

Abbreviations: ACE, angiotensin-converting enzyme; APS, antiphospholipid syndrome; D�HUS, diarrhea-positive hemolytic uremic syndrome; D� HUS, diarrhea-negative hemolytic uremicsyndrome; ESRD, end-stage renal disease; HELLP, hemolysis, elevated liver enzymes, lowplatelet count; HUS, hemolytic uremic syndrome; LDH, lactate dehydrogenase; RBC, red bloodcell; TMA, thrombotic microangiopathy; TTP, thrombotic thrombocytopenic purpura.

aAlso known as atypical HUS.bDrugs include mitomycin C, cisplatin, gemcitabine, vascular endothelial growth factors

bevasizumab), immunosuppressives (cyclosporine, tacrolimus), and other drugs such asuinine and ticlopidine.

Am J Kidney Dis. 2013;61(5):xxv-xxvii

Page 3: Quiz Page MAY 2013

dHsaaaisdcdoembqatonicitetctafTsae

f

M5

ia

tciootsfmptcmtTtctu

C

twS

A

©

h2S

HUS).2 Although one can be confi-ent of the diagnosis of postpartumUS in the clinical setting de-

cribed, the morphologic findingsre not specific to this conditionnd many diseases centeredround the endothelium-plateletnteraction will manifest the sametructural lesions. These includeiarrhea-positive HUS, which ac-ounts for 90% of HUS in chil-ren, and diarrhea-negative HUS,r atypical HUS, which is a dis-ase of the alternative comple-ent pathway. TTP, which should

e reserved for genetic or ac-uired deficit of the enzymaticctivity ofADAMTS13, will showhe same histologic features. Whenther precise causes or mecha-isms of the process are known, its called secondary TMA. Pro-esses that can induce these changesnclude malignant hypertension, an-iphospholipid syndrome, radiationxposure, bone marrow transplanta-ion, scleroderma, medication (cal-ineurin inhibitors, clopidogrel, mi-omycin C, gemcitabine, cisplatin,nti–vascular endothelial growthactor agents, etc), and neoplasias.able 1 lists the diseases respon-ible for TMA, their key features,nd the appropriate treatment forach condition.

How should this patientbe treated?

aternal mortality was as high as

5% in cases of postpartum HUS 2

Am J Kidney Dis. 2013;61(5):xxv-xxvii

n the pre–plasma exchange era,s reported in a series by Weiner.3

Since the introduction of plasmaexchange, the outcome has im-proved significantly, as shown ina more recent series of 11 patientsin which 9 survived.4 Althoughhere was no evidence of signifi-ant red blood cell fragmentationn the peripheral smear, whichften is considered the hallmarkf the disease, this patient wasreated successfully with 6 ses-ions of plasma exchange usingresh frozen plasma as the replace-ent fluid. There was gradual im-

rovement in kidney function overhe next 4 months, with serumreatinine level decreasing to 1.9g/dL (estimated glomerular fil-

ration rate, 31 mL/min/1.73 m2).his case emphasizes the impor-

ance of initiating plasma ex-hange in patients with postpar-um HUS even if there is somencertainty about the diagnosis.

FINAL DIAGNOSISPostpartum HUS.

REFERENCES1. Halevy D, Radhakrishnan J,

Glen Markowitz G, Appel G. Throm-botic microangiopathies. Crit Care

lin. 2002;18:309-320.2. De Serres S, Isenring P. Renal

hrombotic microangiopathy revisited:hen a lesion is not a clinical finding.audi J Kidney Dis Transplant. 2010;

1:411-416.

3. Weiner CP. Thrombotic mi-croangiopathy in pregnancy and thepostpartum period. Semin Hematol.1987;24:119-129.

4. Egerman RS, Witlin AG, Fried-man SA, Sibai BM. Thromboticthrombocytopenic purpura and hemo-lytic uremic syndrome in pregnancy:review of 11 cases. Am J Obstet Gyne-col. 1996;175:950-956.

CASE PROVIDED AND AUTHORED BY

Shashidhar Baikunje, MD,FRCP(UK),1 Mahesha Vank-alakunti, MD,2 and RamaPrakasha Saya, MD,3 1Depart-ment of Nephrology, K.S. HegdeMedical Academy, Deralakatte,Mangalore; 2Department of Ne-phropathology, Manipal Hospital,Bengaluru; and 3Department ofMedicine, K.S. Hegde MedicalAcademy, Deralakatte, Manga-lore, Karnataka, India.

ddress correspondence to ShashidharBaikunje, MD, FRCP(UK), De-partment of Nephrology, K.S.Hegde Medical Academy, De-ralakatte, Mangalore, Karnataka,India. E mail: [email protected] by the National KidneyFoundation, Inc.

ttp://dx.doi.org/10.1053/j.ajkd.012.12.032UPPORT: None.

FINANCIAL DISCLOSURE: The authorsdeclare that they have no relevantfinancial interests.

QU

IZPA

GExxvii